Atlas Trials

Optimizing the Anticoagulation Regimen of Enoxaparin During Percutaneous Coronary Intervention (OPTIENOX-PCI)

Clinical trial NCT03145675 · COMPLETED

Trial details

NCT number
NCT03145675
Sponsor
Peking Union Medical College Hospital
Status
COMPLETED
Phase
Phase 4
Study type
INTERVENTIONAL
Coronary Artery DiseasePercutaneous Coronary Intervention
Start date
2017-05-12
Primary completion
2022-04-20
Enrollment
378

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.